Tag: drug
Hype or Lifesaver? Artificial intelligence is set to revolutionize drug searches
Frankfurt After the IT industry, the pharmaceutical industry is now also increasing its investments in artificial intelligence (AI). This is shown by a number of takeovers and alliances completed in…
Antwerp is arming itself against cocaine smugglers
Antwerp The port of Antwerp lies on the Scheldt like a giant octopus. The numerous side arms allow incoming container ships to be processed at the same time. At 150…
Funds decide on measures against drug shortages
Berlin The statutory health insurance companies (GKV) have decided on measures to alleviate the strained supply of children’s medication. The so-called fixed amounts for certain drugs with the active ingredients…
FDA grants preliminary approval for new Alzheimer’s drug
Frankfurt On Friday evening, the American drug agency FDA granted preliminary approval for the new Alzheimer’s drug lecanemab, thereby raising hopes for further progress in the fight against dementia. The…
Son of drug lord El Chapo arrested in Mexico
Mexico City,. Culiacan The attack took place at dawn: near the city of Culiacán, units of the Mexican Navy and National Guard arrested one of the sons of drug lord…
Son of drug lord El Chapo arrested in Mexico
Gang crime in Mexico After the arrest of the drug lord in the city of Culiacán, criminals blocked buses and trucks on the streets and set the vehicles on fire.…
Risky recipe against bottlenecks Lauterbach wants higher prices for medicines. That doesn’t change anything about the current emergency.
drug It will be a long time before the manufacturers change their production. (Photo: dpa) If even the simplest medicines are no longer available in Germany, something is going terribly…
What Karl Lauterbach’s plans can actually do against the drug shortage
Berlin For Health Minister Karl Lauterbach, the reason for the current bottlenecks in medicines is obvious. “We overdid it with economization,” he said on Tuesday. The SPD politician means the…
The number of new drugs will increase again in 2022
Medicines shelf in the pharmacy This year, more new medicinal active ingredients were brought onto the German market than in a long time. (Photo: imago/Science Photo Library) Frankfurt When it…
Lauterbach plans changes to price rules for children’s medicines
Karl Lauterbach Federal Health Minister Karl Lauterbach (SPD) has announced a draft law for this week. (Photo: IMAGO/Political Moments) Berlin Federal Health Minister Karl Lauterbach (SPD) is planning significant changes…
Medicines: Measures against shortage of medicines required
Drug delivery bottlenecks The Federal Union of German Associations of Pharmacists (ABDA) criticized unnecessary bureaucracy. (Photo: dpa) Berlin Many practices are currently full due to rampant respiratory infections. At the…
Novartis drug against prostate cancer shortly before approval
Frankfurt In Europe, a novel drug against prostate cancer is about to be approved. The drug Pluvicto from the Basel-based pharmaceutical company Novartis promises improved therapy and longer survival times,…
Healthcare industry reacts to rising energy costs
Berlin The high prices for energy and raw materials are also putting massive pressure on the healthcare industry. Only every fourth company in the industry rates its business situation as…
Biontech founders’ cancer drug convinces in study
Ugur Sahin and Özlem Türeci 2018 Before Biontech, Sahin and Türeci founded the Mainz-based biotech company Ganymed. Here they researched a gastric cancer drug whose effectiveness could be proven in…
“The situation has never been so serious”
Berlin The year began with bad news for doctors, pharmacists and cancer patients. In February, the breast cancer drug tamoxifen was suddenly no longer available. A round, white pill –…
Alzheimer’s drug gantenerumab disappointed in clinical studies
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The pharmaceutical company Roche and its German partner Morphosys have to accept a new setback in…
Alzheimer’s drug gantenerumab disappointed in clinical studies
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The pharmaceutical company Roche and its German partner Morphosys have to accept a new setback in…
Roche’s Alzheimer’s drug disappoints in clinical trials
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The Swiss pharmaceutical giant Roche has to cope with another research setback with a new Alzheimer’s…
Cantourage celebrates successful IPO
Cantourage IPO Cantourage offers various medicinal cannabis products. (Photo: Reuters) Dusseldorf Cannabis supplier Cantourage has gotten off to a strong start in the stock market. The shares started trading in…
What the traffic light is planning on self-cultivation and age limit
Karl Lauterbach Federal Minister of Health Karl Lauterbach (SPD) speaks about the planned controlled sale of cannabis to adults in Germany. (Photo: dpa) Berlin Health Minister Karl Lauterbach used to…